Filing Details

Accession Number:
0001493152-19-016105
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-29 17:03:31
Reporting Period:
2019-10-23
Accepted Time:
2019-10-29 17:03:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1412486 Cocrystal Pharma Inc. COCP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1397607 F Raymond Schinazi 1860 Montreal Road
Tucker GA 30084
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-23 3,935 $1.04 9,244,863 No 4 P Direct
Common Stock Acquisiton 2019-10-24 5,094 $1.15 9,249,957 No 4 P Direct
Common Stock Acquisiton 2019-10-25 7,906 $1.15 9,257,863 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 995,593 Indirect By LP
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.965 to $1.08, inclusive. The reporting person undertakes to provide to Cocrystal Pharma, Inc., any security holder of Cocrystal Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the footnote of this Form 4.